Interaction between smoking and glutathione S-transferase polymorphisms in solvent-induced chronic toxic encephalopathy

Toxicology and Industrial Health

Volumn 18, Issue 6, 2002, Pages 289-296

  Ahmadi, Ahmad ^a   Jönsson, Pia ^a   Flodin, Ulf ^a   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

chronic toxic encephalopathy; molecular epidemiology; polymorphism; smoking; solvent exposure

Indexed keywords

DNA; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; ORGANIC SOLVENT;

ARTICLE; CHEMICAL INDUSTRY; CHRONIC DISEASE; CIGARETTE SMOKING; ENZYME POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; XENOBIOTIC METABOLISM;

BRAIN DISEASES; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; SOLVENTS;

EID: 1242337002     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1191/0748233702th152oa     Document Type: Article

References (29)

1. Ahmadi, A., Fredrikson, M., Jerregacrd, H., Akerbacck, A., Fall, P. A., Rannug, A., Axelson, O., Söderkvist, P. 2000: GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset. Biochemical and Biophysical Research Communications 269, 676-680.
2. Anttila, S., Luostarinen, L., Hirvonen, A., Elovaara, E., Karjalainen, A., Nurminen, T., Hayes, J. D., Vainio, H., Ketterer, B. 1995: Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Research 55, 3305-3309.
3. Arlien-Söborg, P. 2000: Solvent neurotoxicity. Boca Raton, FL: CRC Press.
4. Axelson, O. and Hogstedt, C. 1994: The health effects of solvents. In Zenz, C., Dickerson, O., Horvath, E., editors, Occupational medicine. St Louis, MO: Mosby, 764-778.
5. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., Lucier, G. W. J. 1993: Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolismgene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. Journal of the National Cancer Institute 85, 1159-1164.
6. Benhamou, S., Reinikainen, M., Bouchardy, C., Dayer, P., Hirvonen, A. 1998: Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Research 58, 5291-5293.
7. Chen, H., Sandler, D. P., Taylor, J. A., Shore, D. L., Liu, E., Bloomfield, C. D., Bell, D. A. 1996: Increased risk for myelodysplasticsyndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. The Lancet 347, 295-297.
8. Daly, A. K., Thomas, D. J., Cooper, J., Pearson, W. R., Neal, D. E., Idle, J. R. 1993: Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. British Medical Journal 307, 481-482.
9. Deakin, M., Elder, J., Hendrickse, C., Peckham, D., Baldwin, D., Pantin, C., Wild, N., Leopard, P., Bell, D. A., Jones, P., Duncan, H., Brannigan, K., Alldersea, J., Fryer, A. A., Strange, R. C. 1996: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17, 881-884.
10. Farin, F. M. and Omiecinski, C. J. 1993: Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. Journal of Toxicology and Environmental Health 40, 317-335.
11. Guengerich, F. 1982: Epoxide hydrolase: properties and metabolic roles. Reviews of Biochemical Toxicology 4, 4-30.
12. Hassett, C., Aicher, L., Sidhu, J. S., Omiecinski, C. J. 1994: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Human Molecular Genetics 3, 421-428.
13. Hayes, J. D. and Pulford, D. J. 1995: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical Reviews in Biochemistry and Molecular Biology 30, 445-600.
14. Lancaster, J. M., Brownlee, H. A., Bell, D. A., Futreal, P. A., Marks, J. R., Berchuck, A., Wiseman, R. W., Taylor, J. A. 1996: Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Molecular Carcinogenesis 17, 160-162.
15. Löf, A. and Johanson, G. 1998: Toxicokinetics of organic solvents: a review of modifying factors. Critical Review in Toxicology 28, 571-650.
16. McGlynn, K. A., Rosvold, E. A., Lustbader, E. D., Hu, Y., Clapper, M. L., Zhou, T., Wild, C. P., Xia, X. L., Baffoe-Bonnie, A., Ofori-Adjei, D. 1995: Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proceedings of the National Academy of Science USA 92, 2384-2387.
17. Mikkelsen, S. 1995: Solvent encephalopathy;disability pension studies and other case studies. In Chang, L. and Dyer, R., editors, Handbook of neurotoxicology. New York: Dekker, 323-338.
18. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., Taylor, J. B. 1994: Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemistry Journal 300, 271-276.
19. Rowe, J. D., Nieves, E., Listowsky, I. 1997: Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochemistry Journal 325, 481-486.
20. Seidegard, J. and Pero, R. W. 1988: The genetic variation and the expression of human glutathione transferase mu. Wiener klinische Wochenschrift 66 (suppl 11), 125-126.
21. Smith, C. A. and Harrison, D. J. 1997: Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. The Lancet 350, 630-633.
22. Söderkvist, P., Ahmadi, A., Ackerbäck, A., Axelson, O., Flodin, U. 1996: Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy. Scandinavian Journal of Work and Environmental Health 22, 360-363.
23. Statistics Sweden 1965: Statistiska Centralbyra cn. Stockholm.
24. Statistics Sweden 1993: Statistiska Centralbyracn. Stockholm.
25. Takeyabu, K., Yamaguchi, E., Suzuki, I., Nishimura, M., Hizawa, N., Kamakami, Y. 2000: Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. European Respiratory Journal 15, 891-894.
26. Wong, N. A., Rae, F., Bathgate, A., Smith, C. A., Harrison, D. J. 2000: Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicology Letters 115, 17-22.
27. Wormhoudt, L. W., Commandeur, J. N., Vermeulen, N. P. 1999: Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Critical Reviews in Toxicology 29, 59-124.
28. Zhang, H., Ahmadi, A., Ardman, G., Zdolsek, J., Carstensen, J., Nordenskjold, B., Soderkvist, P., Sun, X. F. 1999: Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. International Journal of Cancer 84, 135-138.
29. Zhao, H., Spitz, M. R., Gwyn, K. M., Wu, X. 2002: Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Molecular Carcinogenesis 33, 99-104.